Nuclear magnetic resonance imaging and single photon emission tomography with radio‐iodine labelled compounds in the diagnosis of dementia

K. P. Ebmeier*, J. A.O. Besson, J. R. Crawford, A. N. Palin, H. G. Gemmel, P. F. Sharp, G. R. Cherryman, F. W. Smith

*Corresponding author for this work

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

ABSTRACT— White matter lesions and T1 changes were identified using NMR and then compared between groups of patients suffering from dementia of the Alzheimer type (DAT), Multiple infarct dementia (MID) and normal controls. All DAT and MID patients were also imaged with a gamma camera using 123Iodo‐n‐isopropylamphetamine, a radiopharmaceutical whose uptake in the brain follows the regional blood flow. While NMR was not able to differentiate between DAT and MID, 19 out of 21 DAT patients compared to four out of 18 MID patients showed bilateral parietal lesions on IMP scans.

Original languageEnglish
Pages (from-to)549-556
Number of pages8
JournalActa Psychiatrica Scandinavica
Volume75
Issue number5
DOIs
Publication statusPublished - May 1987

Keywords

  • dementia
  • emission
  • Nuclear Magnetic Resonance
  • tomography

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Nuclear magnetic resonance imaging and single photon emission tomography with radio‐iodine labelled compounds in the diagnosis of dementia'. Together they form a unique fingerprint.

  • Cite this